4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001104659-24-131794
Director bought 397,964 shares at $1.68 ($668,580)
- Director sold 341,633 shares at $1.68 ($573,943)
- Director disposed of 1,084,936 shares (other)
- Director acquired 1,084,936 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC Director | 2024-12-20 | Other disposition | −1,084,936 | $1.68 | $1,822,692 | 11,743,010 | I |
| Redmile Group, LLC Director | 2024-12-20 | Other acquisition | +1,084,936 | $1.68 | $1,822,692 | 12,827,946 | I |
| Redmile Group, LLC Director | 2024-12-20 | Sale | −341,633 | $1.68 | $573,943 | 12,486,313 | I |
| Redmile Group, LLC Director | 2024-12-20 | Purchase | +397,964 | $1.68 | $668,580 | 12,884,277 | I |
| Derivatives | |||||||
| Redmile Group, LLC Director | 2024-12-20 | Other disposition · Class A Convertible Preferred Stock | −116,261 | $8.40 | $976,592 | 2,638,825 | I |
| Redmile Group, LLC Director | 2024-12-20 | Other acquisition · Class A Convertible Preferred Stock | +116,261 | $8.40 | $976,592 | 2,755,086 | I |
| Redmile Group, LLC Director | 2024-12-20 | Other disposition · Cash-settled Swaps | −56,331 | $1.68 | $94,636 | 502,769 | I |
| Open-market purchases · 397,964 sh · avg $1.68 · $668,580 | |||||||
| Open-market sales · 341,633 sh · avg $1.68 · $573,943 | |||||||
Loading xslF345X05/tm2431906-1_4seq1.xml…